Cargando…

Regulation of Mitochondria-Associated Membranes (MAMs) by NO/sGC/PKG Participates in the Control of Hepatic Insulin Response

Under physiological conditions, nitric oxide (NO) produced by the endothelial NO synthase (eNOS) upregulates hepatic insulin sensitivity. Recently, contact sites between the endoplasmic reticulum and mitochondria named mitochondria-associated membranes (MAMs) emerged as a crucial hub for insulin sig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bassot, Arthur, Chauvin, Marie-Agnès, Bendridi, Nadia, Ji-Cao, Jingwei, Vial, Guillaume, Monnier, Léa, Bartosch, Birke, Alves, Anaïs, Cottet-Rousselle, Cécile, Gouriou, Yves, Rieusset, Jennifer, Morio, Béatrice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912364/ https://www.ncbi.nlm.nih.gov/pubmed/31731523 http://dx.doi.org/10.3390/cells8111319

Ejemplares similares

The Role of NO/sGC/cGMP/PKG Signaling Pathway in Regulation of Platelet Function
por: Gambaryan, Stepan
Publicado: (2022)

Hepatitis C virus replication requires integrity of mitochondria-associated ER membranes
por: Duponchel, Sarah, et al.
Publicado: (2022)

Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC/cGMP/PKG Translocation in Experimental Vasospasm
por: Chang, Chih-Zen, et al.
Publicado: (2014)

Corrigendum to “Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC/cGMP/PKG Translocation in Experimental Vasospasm”
por: Chang, Chih-Zen, et al.
Publicado: (2016)

Hypoxia/Reoxygenation of Rat Renal Arteries Impairs Vasorelaxation via Modulation of Endothelium-Independent sGC/cGMP/PKG Signaling
por: Braun, Diana, et al.
Publicado: (2018)

Effect of Metformin on T2D-Induced MAM Ca(2+) Uncoupling and Contractile Dysfunction in an Early Mouse Model of Diabetic HFpEF
por: Dia, Maya, et al.
Publicado: (2022)

Structural insights into sGC
por: Akker, Focco van den, et al.
Publicado: (2009)

Liraglutide prevents and reverses monocrotaline-induced pulmonary arterial hypertension by suppressing ET-1 and enhancing eNOS/sGC/PKG pathways
por: Lee, Mei-Yueh, et al.
Publicado: (2016)

Helicid Reverses the Effect of Overexpressing NCALD, Which Blocks the sGC/cGMP/PKG Signaling Pathway in the CUMS-Induced Rat Model
por: Zhang, Xiao-Tong, et al.
Publicado: (2021)

Serum IgG-induced microglial activation enhances neuronal cytolysis via the NO/sGC/PKG pathway in children with opsoclonus-myoclonus syndrome and neuroblastoma
por: Ding, Xu, et al.
Publicado: (2020)

Retracted: Helicid Reverses the Effect of Overexpressing NCALD, Which Blocks the sGC/cGMP/PKG Signaling Pathway in the CUMS-Induced Rat Model
por: Healthcare Engineering, Journal of
Publicado: (2023)

Molecular aspects of sGC regulation
por: Marletta, Michael A, et al.
Publicado: (2011)

Targeting native and apo-sGC
por: Struthers, Mary, et al.
Publicado: (2013)

sGC redox regulation and asthma
por: Stuehr, Dennis J, et al.
Publicado: (2015)

Mitochondria-associated membranes (MAMs) and pathologies
por: Pinton, Paolo
Publicado: (2018)

Mitochondria-associated membranes (MAMs) and inflammation
por: Missiroli, Sonia, et al.
Publicado: (2018)

New clinical results with sGC stimulators
por: Behr, Jürgen
Publicado: (2011)

Synthesis and evaluation of bifunctional sGC regulators
por: Chrominski, Mikolaj, et al.
Publicado: (2013)

Conformational changes involved in sGC activation
por: Marletta, Michael A, et al.
Publicado: (2013)

Lack of correlation between sGC subunit expression and sGC activity in cerebral development is due to non-heterodimerizing subunits in vivo
por: Haase, Nadine, et al.
Publicado: (2009)

A Zebrafish Drug-Repurposing Screen Reveals sGC-Dependent and sGC-Independent Pro-Inflammatory Activities of Nitric Oxide
por: Wittmann, Christine, et al.
Publicado: (2015)

Synergistic mutations in soluble guanylyl cyclase (sGC) reveal a key role for interfacial regions in the sGC activation mechanism
por: Childers, Kenneth C., et al.
Publicado: (2019)

A molecular view of the regulation of sGC activity
por: Marletta, Michael A, et al.
Publicado: (2009)

Structural insights into sGC activation by different activators
por: van den Akker, Focco, et al.
Publicado: (2011)

Genetic modifiers of hypertension in sGC-deficient mice
por: Buys, Emmanuel
Publicado: (2013)

The clinical development of sGC modulators, riociguat and vericiguat
por: Misselwitz, Frank
Publicado: (2015)

Calcium signaling around Mitochondria Associated Membranes (MAMs)
por: Patergnani, Simone, et al.
Publicado: (2011)

New vitamin B(12) derivatives activates sGC
por: Gryko, Dorota, et al.
Publicado: (2011)

Gemfibrozil as a potential heme-independent sGC activator
por: Sobolevsky, Michael, et al.
Publicado: (2011)

Mitochondria-associated ER membranes (MAMs) and lysosomal storage diseases
por: Annunziata, Ida, et al.
Publicado: (2018)

Molecular Dysfunctions of Mitochondria-Associated Membranes (MAMs) in Alzheimer’s Disease
por: Eysert, Fanny, et al.
Publicado: (2020)

sGC activators and stimulators attenuate ischemia/reperfusion injury of the lung
por: Egemnazarov, Bakytbek, et al.
Publicado: (2009)

Phenotypes of sGC mutant mice in basic conditions, disease and shock
por: Brouckaert, Peter, et al.
Publicado: (2009)

Inhaled nitric oxide: an sGC-dependent IOP lowering agent
por: Lieb, Wolfgang S, et al.
Publicado: (2015)

There's Something Wrong with my MAM; the ER–Mitochondria Axis and Neurodegenerative Diseases
por: Paillusson, Sebastien, et al.
Publicado: (2016)

Connection Lost, MAM: Errors in ER–Mitochondria Connections in Neurodegenerative Diseases
por: Johri, Ashu, et al.
Publicado: (2021)

Genetic silencing of sGC β1 in cancer: role of epigenetic regulation
por: Sotolongo, Alex, et al.
Publicado: (2013)

Is Innervation of the Neuromuscular Junction at the Diaphragm Modulated by sGC/cGMP Signaling?
por: Lukáčová, Nadežda, et al.
Publicado: (2020)

sGC Activity and Regulation of Blood Flow in a Zebrafish Model System
por: Vishnolia, Krishan K., et al.
Publicado: (2021)

Aortic disease in Marfan syndrome is caused by overactivation of sGC-PRKG signaling by NO
por: de la Fuente-Alonso, Andrea, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pmfvhji8q2sv8hpm4r8ih7nafr